SEC EDGARSEP 101 min read$LRCX

ARCHER TIMOTHY sold $9.6M of LRCX

ARCHER TIMOTHY (President and CEO) sold 30,000 shares of LAM RESEARCH CORP (LRCX) at $319.26 ($9.58M total) on 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · ARCHER TIMOTHY

Published Sep 10, 2026, 5:05 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 10, 2026, 5:44 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$LRCX

Bearish

medium confidence

Mentioned

$LRCX

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$LRCXBearishLow

Why it matters

The disclosed sale adds a modest negative data point but is unlikely to trigger a major move unless accompanied by other signals.

Market read

Primary insider sale provides fresh, material information for traders monitoring LRCX.

What to watch

The sale was pre‑arranged under a 10b5‑1 plan, reducing the informational content of the trade.

Relevance 5/10Novelty 6/10Timing: filing disclosed today

Background

Lam Research is a leading supplier of wafer fabrication equipment; CEO insider sales are monitored by investors.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$LRCXBearishMedium confidence

Context

SEC Form 4 shows CEO Archer Timothy sold 30,000 shares for $9.58M via a 10b5-1 plan.

Expected impact

Possible modest dip in LRCX price over the next few days.

Evidence & confidence

CEO sale of $9.6M is material for a mid‑cap chip equipment maker; market may interpret as a negative signal.

Market effects

Sector

May raise concerns for semiconductor equipment sector if other insiders follow suit.

Regional

Limited to U.S. markets where LRCX trades.

Global

Low global impact beyond investors tracking chip‑equipment stocks.

Counterpoint

What could challenge this read

Insider sales can be routine liquidity events; the market may already price this in.

Key entities

Person
Archer Timothy
President and CEO of Lam Research
Company
Lam Research Corp.
Semiconductor equipment manufacturer (ticker LRCX)

Read at source ← All news

OCT 13

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

tradingview.com2 min

OCT 13

$AMATMed

Applied Materials shares slide as chip equipment outlook remains uncertain

Applied Materials (AMAT) shares dropped 7.5% after it declined to provide a wafer fabrication equipment (WFE) spending forecast, citing uncertainties. CEO Gary Dickerson expressed long-term confidence in AI-driven demand but highlighted near-term variables. Semiconductor equipment peers KLA Corp., Lam Research, and ASML Holding also fell. ASML's upcoming earnings are in focus.

investing.com4 min

OCT 9

$LRCXHigh

Wells Fargo Adjusts Price Target on Lam Research to $355 From $350

Wells Fargo raised its price target for Lam Research (LRCX) to $355 from $350. Morgan Stanley also adjusted its target to $385 from $367, maintaining an overweight rating. LRCX shares closed at $320.59, down 2.71%.

marketscreener.com1 min

OCT 9

$LRCXLow

Round Design Infringement Case Against Lam Research < Supply Chain < 기사본문

BCNC, a South Korean semiconductor component maker, was ordered by a Seoul court to stop producing and distributing certain edge-ring products, pay damages, and destroy existing inventory, following a design-right infringement lawsuit by Lam Research. The court partially dismissed Lam Research's claims. Both companies are also involved in separate patent disputes, with mixed rulings. BCNC plans to appeal the decision.

thelec.net2 min

OCT 8

$LRCXMedAI 8/10

Lam Research Stocks Fall 2.1% as AI Spending Lifts Target 33%

Lam Research (LRCX) shares fell 2.42% to $325.81 on October 7, despite Cantor Fitzgerald raising its price target to $425 from $320. The company reported June-quarter revenue of $6.72 billion, up 15.1% from the prior quarter, with improved margins. Cantor's target suggests 30.4% upside, but shares are 106.68% above GF Value™ estimate of $157.64.

gurufocus.com2 min

OCT 6